The Role of CD38 in Regulatory T Cells
Author Information
Author(s): Daniel T. Patton, Marcus D. Wilson, Wendy C. Rowan, Dalya R. Soond, Klaus Okkenhaug
Primary Institution: Babraham Institute, Cambridge, United Kingdom
Hypothesis
The study investigates the role of the PI3K p110δ in regulating CD38 expression on regulatory T cells and its impact on their suppressive ability.
Conclusion
CD38 can be used as a marker for identifying regulatory T cells with high suppressive activity, and its expression is regulated by the PI3K pathway.
Supporting Evidence
- CD38high regulatory T cells showed superior suppressive activity compared to CD38low Tregs.
- Reduced CD38 expression in p110δD910A Tregs correlates with impaired suppressive function.
- CD38 expression is regulated by the PI3K pathway during Treg development.
Takeaway
This study found that a protein called CD38 helps some immune cells called regulatory T cells do their job better, and that a specific pathway in cells controls how much of this protein they have.
Methodology
The researchers compared the transcriptome of wild-type and p110δD910A regulatory T cells using microarray analysis and validated findings with qRT-PCR.
Limitations
The study primarily focuses on mouse models, which may not fully translate to human biology.
Participant Demographics
Mice used in the study included CD38−/−, p110δD910A, and RAG2−/− strains.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website